2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Por: Zamorano, JL, Lancellotti, P, Munoz, DR, Aboyans, V, Asteggiano, R, Galderisi, M, Habib, G, Lenihan, DJ, Lyon, AR, Lopez Fernandez, T, Mohty, D, Tamargo, J, Suter, TM, Baron-Esquivias, G, Baumgartner, H, Bax, JJ, Dean, V, Kolh, P, Lip, GYH, Nihoyannopoulos, P, Piepoli, MF, Torbicki, A, Achenbach, S, Minotti, G, Agewall, S, Badimon, L, Bueno, H, Cardinale, D, Carerj, S, Curigliano, G, de Azambuja, E, Dent, S, Erol, C, Ewer, MS, Farmakis, D, Fietkau, R, Fitzsimons, D, Gaemperli, O, Kirchhof, P, Kohl, P, McGale, P, Ponikowski, P, Ringwald, J, Roffi, M, Schulz-Menger, J, Stebbing, J, Steiner, RK, Szmit, S, Carneiro, AV, Windecker, S

---

Publicada: 21 sep 2016

---

---

Filiaciones:
Zamorano, JL:
 Univ Hosp Ramon y Cajal, Cardiol, Carretera Colmenar Km 9-100, Madrid 28034, Spain

Lancellotti, P:
 Centre Hospitalier Universitaire de Liege, Liege, Belgium

Badimon, L:
 Institut dInvestigació Biomèdica Sant Pau IIB Sant Pau, Barcelona, Spain